Conference Details

2008 Best Practices in Pediatrics 11/15/2008

Renaissance Hollywood Hotel
1755 N. Highland Avenue
Hollywood , CA 90028
Phone: 323-856-1200

Who Should Attend

All pediatric or primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.

Agenda

11/15/2008 6:30 am - 7:30 am Registration and Complimentary Continental Breakfast 7:30 am - 12:10 pm Sessions 1, 2, & 3 (each session followed by a 15 minute break) 12:10 pm - 12:40 pm Complimentary Lunch 12:40 pm - 3:30 pm Sessions 4, & 5 (each session followed by a 10-15 minute break)

Venue Information

Meeting Room: Hollywood Ballroom

Self Parking: $10/day
Valet Parking: $17 for a 10 hour maximum for event valet and $29/day for overnight valet
Parking rates are subject to a 10% City Parking Tax.

Accreditation

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
This activity has been reviewed and is acceptable for up to 6.75 Prescribed credits by the American Academy of Family Physicians.

AAP
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for up to 6.75 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

AANP
This program has been approved for 6.66 contact hours of continuing education (which includes 3.33 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0809460.

AAPA
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.

Topics

Asthma   Comprehensive Management of Pediatric Asthma: Using the Guidelines to Develop Effective, Long-term Plans Overview This educational activity is designed to give clinicians an overview of asthma as a heterogeneous disease and its implication for individual treatment. It will also provide guidance for using the NAEPP EPR 3 guidelines as part of a comprehensive, long-term asthma management plan custom tailored for the needs of each individual patient. NAEPP EPR 3 domains of asthma control include measures of assessment and monitoring; control of factors that contribute to asthma severity; pharmacologic therapy; and education for a partnership in asthma. Objectives Understand why the updated NAEPP EPR 3 guidelines are useful in treatment of pediatric patients with asthma and name the 2 domains for assessing asthma control Name the symptoms of asthma and understand how to effectively monitor their asthma patients by naming the specific time intervals to ensure that patients maintain optimal control Faculty Erwin W. Gelfand, MD Chairman, Department of Pediatrics National Jewish Medical and Research Center Professor of Pediatrics and Immunology University of Colorado Denver, CO   ADHD   Translating Evidence to Practice - Advances in the Management of ADHD Overview Using the latest evidence related to the safety, efficacy, and tolerability profiles of current treatment options, combined with improved skills in recognition and diagnosis, physicians can be poised to deliver up-to-date, evidence-based care to their patients with ADHD. Objectives Recognize the importance of early identification of symptoms for improved diagnosis and treatment of children and adolescents with ADHD Compare and contrast the current treatment options for children and adolescents with ADHD and develop individualized management strategies for each patient Faculty Peter Knoblich, MD Physician, Private Practice Roseville, CA James McCracken, MD Joseph Campbell Professor and Director, Division of Child and Adolescent Psychiatry, UCLA Neuropsychiatric Institure and Hospital in Los Angeles, David Geffen School of Medicine at UCLA   Meningococcal Disease   Preventing Meningococcal Disease: Defining Risk and Differentiating Serogroups Overview This program is designed to provide a critical update to physicians on the best measures currently available to prevent meningococcal disease in their patients. This includes the latest evidence-based research on specific serotypes of meningococcus and the specific vaccines directed against them, the efficacy and safety of these vaccines, the most recent guidelines of the CDC and ACIP, and the most effective means of communicating with their patients and achieving the highest rates of vaccination possible against this disease. Objectives Identify patient groups at high risk for meningococcal infection and employ effective screening procedures and routine review of immunization records to ensure appropriate vaccination rates Understand the correspondence between the strains or serogroups of N meningitidis prevalent in the U.S. and the characteristics such as vaccine class (polysaccharide, conjugate), specificity for one or more strains, efficacy, and safety of the currently approved vaccines Faculty Lawrence Ross, MD Hospital Infection Control Officer Professor of Pediatrics Childrens Hospital Los Angeles Keck School of Medicine University of Southern California Los Angeles, CA Richard G. Judelsohn, MD Managing Partner Buffalo Pediatric Associates Medical Director Erie County Health Department Buffalo, NY   Rotavirus   Tools for Managing Rotavirus and Understanding Disease Prevention Overview This CME activity will provide primary care clinicians with the tools needed to better understand rotavirus prevention and management. The goal of this educational activity is to provide primary care clinicians with the education to work toward decreasing the overall impact of rotavirus in the US. Objectives Expand clinician knowledge of the safety and efficacy of the rotavirus vaccine and risk benefits and increase the level of effective management of rotavirus for those patients who have not received the vaccine Describe the ages at which it is appropriate to administer the rotavirus vaccine and name one method to help prevent rotavirus transmission within the home setting Faculty Mary Beth Koslap-Petraco, MS, APRN-BC, CPNP Clinical Assistant Professor Stony Brook University School of Nursing Coordinator, Child Health Patient Care Division Suffolk County Department of Health Services Hauppauge, New York   HPV   Integrating HPV Vaccination Into Contemporary Pediatric Practice: Strategies for Success Overview Human papillomavirus (HPV) is the most common newly acquired sexually transmitted infection in the United States. It is a necessary cause of cervical cancer and genital warts, and is associated with other anogenital and head and neck cancers, and recurrent respiratory papillomatosis. As HPV is most prevalent among young, sexually active individuals, prevention through prophylactic HPV vaccination of preadolescents and adolescents before they become sexually active provides the maximum health benefit. Two vaccines have been developed: a quadrivalent HPV (6, 11, 16, 18) vaccine, approved by the US Food and Drug Administration (FDA), and a bivalent HPV (16, 18) vaccine, currently under FDA review. Both vaccines have demonstrated lasting efficacy against HPV-associated cervical disease and are generally well tolerated. This program will review the health consequences of HPV infection, provide an update on the safety and efficacy of HPV vaccines, including recent data to expand the benefits of vaccination, and address common barriers to implementing HPV vaccination into pediatric practice. Objectives Describe the health consequences associated with HPV infection Discuss the benefits of HPV vaccination with adolescent patients and their parents Faculty Richard E. Rupp, MD Associate Director, Division of Adolescent and Behavioral Medicine Associate Professor of Pediatrics University of Texas Medical Branch at Galveston Galveston, TX Lawrence S. Friedman, MD Professor of Pediatrics and Internal Medicine University of California, San Diego Medical Director, Ambulatory Care and Quality and Safety UCSD Medical Center San Diego, CA

Primary Care Network complies with the Americans with Disabilities Act. If you require special services to support your participation in this continuing education program, contact us directly
at 877-594-1770.

Overnight accommodations and parking fees are the responsibility of the participant of this CME activity. Please contact the hotel hosting this program to book overnight accommodations.